-
.png)
Why exhibit at DPC2022?
18 Nov 2021Many of our exhibitors and sponsors return year on year – and with access to thousands of prescribers, payers and influencers, they have good reason to.
DPC2022 will bring you into direct, face-to-face contact with thousands of professionals with the responsibility for prescribing, recommending, commissioning and financing diabetes care.
-
)
“One of the best opportunities for professional upskilling in the UK” – DPC2021 visitors give their feedback
18 Nov 2021Visitors and exhibitors made a welcome return to the first in-person DPC in two years.
Networking, sharing good practice and informal catch-ups were enjoyed once again as HCPs reunited with the aim of ‘re-booting’ diabetes care.
-
)
Thousands of healthcare professionals received vital education at Diabetes Professional Care 2021 this week to help the NHS reboot diabetes care.
The buzz was back as the diabetes professional community came together at DPC2021, which took place at Olympia London on 10 and 11 November, representing the first in-person diabetes event in two years.
-
)
-
Global Head of Roche Diabetes Care, Marcel Gmünder, discusses some of the topics that Roche Diabetes Care will cover at this year’s DPC, including their vision for integrated Personalised Diabetes Management, their digital tools to support healthcare professionals and people with diabetes and the recently launched new Accu-Chek® Instant system.
-
DPC to showcase pioneering companies at the Edge
08 Nov 2021Innovative new businesses will have the chance to display their state-of-the-art products, services and care at DPC2021. -
A renowned diabetes consultant working in paediatric diabetes and endocrinology will explore the complexities of managing diabetes in young people at this year’s DPC2021. -
Unlocking the power of data with Glooko®
08 Nov 2021Transforming digital health underpins all that Glooko® does, and the company is looking forward to demonstrating its platforms at DPC2021. -
A leading diabetes organisation is to release new guidelines on the impact of SGLT-2 inhibitors for people living with chronic kidney disease (CKD) in December 2021.
-
)
A trailblazing new product which detects vascular disease and offers an alternative to traditional ABpI tests will be showcased at this year’s DPC.
News
Sponsors
Diamond Sponsor
Platinum Sponsor
Platinum Sponsor
Platinum Sponsor
Platinum Sponsor
Gold Sponsor
Silver Sponsor
-(002).jpg){kind=logo}
Registration Sponsor
